Veterinary Cardiology Market Report 2026

Veterinary Cardiology Market Overview

• Veterinary Cardiology market size has reached to $3.1 billion in 2025 • Expected to grow to $4.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Rising Cases Of Heart Diseases In Pets And Livestock Driving Veterinary Cardiology Market Expansion • Market Trend: Advancements In Veterinary Cardiology With Minimally Invasive TEER Procedure For Treating Heart Disease In Dogs • North America was the largest region in 2025.

What Is Covered Under Veterinary Cardiology Market?

Veterinary cardiology is the branch of veterinary medicine focused on identifying and managing animal heart diseases, ranging from routine examinations to advanced treatments. It enhances the quality of life for pets by providing specialized diagnosis and treatment for heart conditions, leading to improved health outcomes and extended lifespans. The main product types of veterinary cardiology include pharmaceuticals and diagnostics. Pharmaceuticals in veterinary cardiology refer to the medications used to treat heart conditions in animals for managing heart failure, arrhythmias, and other cardiovascular issues. The indications included are congestive heart failure, myocardial (heart muscle) disease, arrhythmias, others for animal types such as companion animals, and production animals. The end users include veterinary hospitals, clinics, and others.

What Is The Veterinary Cardiology Market Growth Forecast?

The veterinary cardiology market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising adoption of telemedicine in veterinary cardiology, growth in pet insurance coverage, development of AI-enabled diagnostic tools, increased focus on preventive and personalized cardiac care, expansion of companion animal population in urban regions. Major trends in the forecast period include telecardiology & remote cardiac monitoring, minimally invasive cardiac procedures, personalized treatment plans for companion animals, advanced cardiac imaging techniques, nutraceuticals & preventive cardiac care.

Global Veterinary Cardiology Market Segmentation

1) By Product: Pharmaceuticals, Diagnostics 2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications 3) By Animal Type: Companion Animals, Production Animals 4) By End-User: Veterinary Hospitals, Clinics, Other End Users Subsegments: 1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health 2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring

What Is The Driver Of The Veterinary Cardiology Market?

The rising cases of heart diseases in pets and livestock are expected to propel the growth of the veterinary cardiology market going forward. Heart diseases in pets and livestock refer to medical conditions that affect the heart's structure and function, leading to impaired blood circulation, reduced cardiac efficiency, and potential complications in overall health. The rising cases of heart diseases in pets and livestock are driven by factors such as increased lifespan, obesity, poor diet, genetic predispositions, and a lack of regular veterinary care. Additionally, environmental stressors and changes in living conditions can contribute to the prevalence of cardiovascular conditions in these animals. Veterinary cardiology helps diagnose, treat, and manage heart diseases in pets and livestock through specialized care, advanced imaging, and innovative procedures like minimally invasive surgeries to improve heart health and quality of life. For instance, in March 2024, according to the American Veterinary Medical Association, a US-based not-for-profit organization, Myxomatous mitral valve degeneration (MMVD) is the most prevalent heart disease in dogs in North America, making up 75% of all canine cardiac conditions. It is reported that 85% of small dogs aged 13 years show signs of a myxomatous mitral valve lesion, although the presence of a lesion does not necessarily have clinical significance. In cases of MMVD, the estimated rate of cardiac-related deaths in dogs is between 40% and 70%. Therefore, the rising cases of heart diseases in pets and livestock will drive the growth of the veterinary cardiology industry.

Key Players In The Global Veterinary Cardiology Market

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet

Global Veterinary Cardiology Market Trends and Insights

Major companies operating in the veterinary cardiology market are developing technological advancements, such as transcatheter edge-to-edge mitral valve repair (TEER), to improve the treatment of heart diseases in animals, enhance surgical outcomes, and offer minimally invasive alternatives for better patient recovery and quality of life. Transcatheter edge-to-edge mitral valve repair (TEER) is a less invasive heart procedure designed to fix mitral valve leakage by using a clamp to improve valve function and reduce heart strain. For instance, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral center, launched a groundbreaking heart treatment for dogs to treat myxomatous mitral valve disease (MMVD), which is the most common heart condition in dogs. It is now regarded as a viable alternative to surgical repair in human patients, with early clinical results in dogs showing great promise. The procedure is conducted under general anesthesia through a minor incision in the chest wall. A needle is inserted at the heart’s apex, with precise guidance provided by continuous X-rays and transesophageal ultrasound. This method facilitates the accurate placement of a V-clamp across the mitral valve to minimize leakage.

What Are Latest Mergers And Acquisitions In The Veterinary Cardiology Market?

In October 2023, EQT AB, a Sweden-based investment organization, acquired VetPartners for $940 million. This acquisition supports EQT's strategy to broaden its investment portfolio within the animal health sector, aiming to elevate the standard of veterinary services and address the increasing demand for animal healthcare in the region. VetPartners is a UK-based veterinary group providing comprehensive cardiology care and services to animals.

Regional Outlook

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Cardiology Market?

The veterinary cardiology market consists of revenues earned by entities by providing services such as educational services, emergency care, telemedicine services, follow-up care, and consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. veterinary cardiology market also includes sales of monitoring devices, treatment products, supportive products, and surgical products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.